Call: 1-800-887-8100

 

New here?
Please register Already a member?
Sign in now

 
About COPAXONE(R) Taking COPAXONE(R) Your Immune System About Multiple Sclerosis About Shared Solutions(R) Available Therapies
  Share Print

Remember why you chose COPAXONE®

Now is a great time to think about why you chose COPAXONE®, and why it continues to be a smart choice, even as the multiple sclerosis treatment landscape changes.

Immune Smart

COPAXONE® is a smart choice


More reasons to stay committed

Recent studies have highlighted the everyday benefits of taking COPAXONE®8,9


Listen to what this long-term COPAXONE® user has to say about why he stays committed


Video Title Mental & Physical Empowerment
Terry, on COPAXONE® for RRMS since 2002

Stay motivated!

We know that managing a disease over the long term can pose unique motivational challenges. If you ever feel like your treatment plan could use some reenergizing, you might want to:

  • Revisit the goals you set for yourself when you first started therapy
  • Remember, you’re doing this for yourself and your loved ones
  • Think about the things that have motivated you along this journey
  • Take advantage of your support network
    • Health care providers can share their experience from working with many patients to help you stay focused
    • Friends and family are your CarePartners—ask for their help

Call Shared Solutions® at 1-800-887-8100

We're always here to help

  • One-on-one peer support
  • Financial and benefits investigation assistance
  • COPAXONE Co-pay Solutions™
  • 24/7 support from MS-certified nurses

Find out more about Shared Solutions®  and the services we provide to help you stay committed, such as refresher training and injection tips.



Current rating: 3 (7 ratings)
References:
1. Weber MS, Hohlfeld R, Zamvil SS. Neurotherapeutics. 2007;4(4):647-653. 2. Miller A, Shapiro S, Gershtein R, et al. J Neuroimmunol. 1998;92(1-2):113-121. 3. COPAXONE® (glatiramer acetate injection) prescribing information. Teva Neuroscience, Inc. 4. Ford C, Goodman AD, Johnson K, et al. Mult Scler. 2010;16(3):342-350. 5. O’Connor P, Filippi M, Arnason B, et al; for the BEYOND Study Group. Lancet Neurol. 2009;8(10):889-897. 6. Mikol DD, Barkhof F, Chang P, et al; on behalf of the REGARD study group. Lancet Neurol. 2008;7(10):903-914. 7. Comi G, Martinelli V, Rodegher M, et al; for the PreCISe study group. Lancet. 2009;374(9700): 1503-1511. 8. Khan O, Mackenzie M, Bao F, et al. Poster presented at: 60th Annual Meeting of the American Academy of Neurology; April 12-19, 2008; Chicago, IL. PO8.173. 9. Castelli-Haley J, Oleen-Burkey MA, Lage MJ. Poster presented at: 10th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research; October 20-23, 2007; Dublin, Ireland.
COP112012817/111544
  • COPAXONE® (glatiramer acetate injection) is indicated for the reduction of the frequency of relapses in relapsing-remitting multiple sclerosis, including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

Important Safety Information About COPAXONE®

  • The most common side effects of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These reactions are usually mild and seldom require professional treatment. Be sure to tell your doctor about any side effects.

    Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems.

    A permanent indentation under the skin at the injection site may occur, due to a local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

    After you inject COPAXONE®, call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, severe pain at the injection site or other uncomfortable changes in your general health. Do not give yourself any more injections until your doctor tells you to begin again.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

#1 Prescribed RRMS therapy in the US*

Suggested articles

Benefits & Insurance Assistance

COPAXONE Co-pay Solutions™

Therapy and Immune Health

10 Tips for CarePartners

Choosing a Therapy

Your MS Online Planner

My recent articles

Daily Life

COPAXONE® FAQs

Helpful Links

Glossary
From relationships to aging to travel, get the scoop in our
Daily Life section.
More SolutionsTrack your injections, your appointments ... your life. Set up your More Solutions Planner.
TerryI have MS every day so why not treat it every day?

—Terry H., on COPAXONE® RRMS since 2002
master_PDF.png  Download Adobe Acrobat
*IMS Health National Prescription Audit, May 2011. Data is proprietary to IMS Health.
 

COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered trademark of Teva Neuroscience, Inc. autoject® 2 for glass syringe is a registered trademark of Owen Mumford, Ltd. COPAXONE CO-PAY SOLUTIONS™ is a trademark of Teva Pharmaceutical Industries Ltd. © 2011, Teva Neuroscience, Inc. All Rights Reserved. This site is intended for US residents only.

The brands listed are the trademarks and registered trademarks of their respective owners.